BARICOL Rectal Suspension 1.05 Grams
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
11-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BARIUM SULFATE
Available from:
E-Z-EM Nederland B.V.
Dosage:
1.05 Grams
Pharmaceutical form:
Rectal Suspension
Authorization date:
2002-12-17
Summary of Product characteristics
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Baricol 1.05 g/ml Rectal Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Barium Sulphate 1.05 g/ml.
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Rectal Suspension
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
This medicinal product is for diagnostic use only.
‘Baricol’ is a radiopaque diagnostic agent for use in air double contrast X-ray visualisation of the lower gastro-
intestinal tract.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
‘Baricol’ is intended for rectal (enema) administration. The dosage administered will be dependent upon the patient and
the technique involved and will be determined from experience by the radiologist.
ADULTS: The volume administered will normally be about 600 ml.
CHILDREN: The quantity of ‘Baricol’ should be determined, from experience, by the physician and will be dependent on
the age and weight of the child.
ELDERLY: Radiological examinations in the elderly should be carried out with extreme care and the dosage determined
by the radiologist.
At the time of the examination the large bowel should be free of any residues that may interfere with the X-ray
examination.
4.3 CONTRAINDICATIONS
‘Baricol’ should not be used in patients with unclear abdomen with irritated peritoneum and known or suspected
perforation; postoperative suture insufficiency, intestinal fistulae with a passage to the mediastinum, pleural cavity or
peritoneal cavity; fresh injuries or chemical burns of the oesophageal-gastro-intestinal tract, ischemia of the intestinal
wall, necrotising enterocolitis and immediately before surgery of the gastro-intestinal tract.
It should not be used in patients with hypersensitivity to barium sulphate or to any of the excipients.
IRISH MEDICINES BOARD
_____
Read the complete document
